DOSAGE REGIMENS FOR HCV COMBINATION THERAPY COMPRISING BI201335, INTERFERON ALPHA AND RIBAVIRIN

DOSAGE REGIMENS FOR HCV COMBINATION THERAPY COMPRISING BI201335, INTERFERON ALPHA AND RIBAVIRIN

Patent No. 598465 Disclosed is the use of a therapeutic combination comprising: (a) Compound (1) or a pharmaceutically acceptable salt thereof: (b) an interferon alpha; and (c) ribavirin, in the preparation of a medicament for treating hepatitis C viral (HCV) infection or alleviating one more sympto...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: STERN, JERRY O, STEINMANN, GERHARD, HAEFNER, CARLA
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Patent No. 598465 Disclosed is the use of a therapeutic combination comprising: (a) Compound (1) or a pharmaceutically acceptable salt thereof: (b) an interferon alpha; and (c) ribavirin, in the preparation of a medicament for treating hepatitis C viral (HCV) infection or alleviating one more symptoms thereof in a patient, wherein the first dose of Compound (1), or a pharmaceutically acceptable salt thereof, is formulated for administration to the patient double in quantity by weight to the subsequent doses thereof.